Biogen
Manufacturing · Massachusetts, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
225 Binney St, Cambridge, Massachusetts,...Phone Number
(781) 464-2000Website
www.biogen.comRevenue
$9.9 BillionStock Symbol
BIIBIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
22
1
3
3
2
2
About Biogen
Biogen is a U.S.-based biotechnology company focused on discovering, developing, and commercializing therapies for serious neurological and neurodegenerative diseases. Its core portfolio includes treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and other rare neurological disorders, supported by advanced research in neuroscience, biologics, and gene-based therapies.Explore more
Biogen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Biogen has recently received funding, and reach out quickly before it becomes old news!
Click to see if Biogen had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Biogen has new funding data
Congratulate Masked Content for being promoted to Masked Content at Biogen
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Biogen recently announced quarterly report
Product Launch: Get notified when Biogen launches new products
Biogen, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Biogen is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Biogen
Compare insights from companies similar to Biogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$29.7B
10K+
Public
$296.3M
1987
Srihari NarasimhanStrategic Initiatives Lead & To The Chief of Staff & Chief Financial Officer
$1.4B
1K - 5K
Private
$18M
1992
SG
Sean GormanDirector, Business Planning & Operations Medical Office Chief & Chief Marketing Officer
Company Profile Activity
Activity Insights
Biogen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biogen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biogen.
Biogen Tech Stack
A closer look at the technologies used by Biogen
Most Recent Scoops
Project
Spending/Investment, Lawsuits, Legal Affairs, Settlement
Person-Based
Pharmaceuticals, Corporate Strategy
Open Position
Open Position
Open Position
Biogen News & Media
Why Biogen Stock Topped the Market Today
The company published its second-quarter results on Wednesday morning.Biogen Inc. (BIIB) Q2 2026 Earnings Call Transcript
Biogen Inc. (BIIB) Q2 2026 Earnings Call July 29, 2026 8:30 AM EDTCompany ParticipantsTim Power - Head of Investor RelationsChristopher Viehbacher -...Biogen Q2 Earnings Call Highlights
Biogen (NASDAQ:BIIB) reported second-quarter 2026 total revenue of $2.7 billion, up 3% from a year earlier, as growth products and the recently completed acquisition of Apellis contributed to results. Core pharmaceutical revenue rose 4% year over year to $1.8 billion, while the company’s growth portBiogen beats quarterly estimates as newer drugs fuel growth
July 29 () - Biogen reported second-quarter profit and revenue that topped Wall Street estimates on Wednesday, driven by strong demand for its rare-disease medicines, while sales of its legacy multiple sclerosis drugs stayed under pressure. Investors are closely watching whether recent deals and newer products including its Alzheimer's drug Leqembi can reignite growth and help the company navigate mounting competition and pricing pressure across its aging multiple sclerosis portfolio.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biogen
Sign Up For FreeTo access detailed company insights
Biogen is a U.S.-based biotechnology company focused on discovering, developing, and commercializing therapies for serious neurological and neurodegenerative diseases. Its core portfolio includes treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and other rare neurological disorders, supported by advanced research in ne... Read More
